Literature DB >> 2832524

In vitro transcription and translation of bluetongue virus mRNA.

A A Van Dijk1, H Huismans.   

Abstract

Fractionation of in vitro transcribed bluetongue virus (BTV) mRNA by agarose gel electrophoresis resulted in the separation of eight of the 10 species. The relative molar ratio of the mRNAs confirmed that mRNA 5 was transcribed more frequently than would be predicted from the size of the S5 genome segment, while mRNA 10 was transcribed less frequently. In vitro translation of unfractionated BTV mRNAs resulted in the synthesis of the seven known structural proteins (P1 to P7) and two known non-structural proteins (NS1 and NS2). Two additional non-structural proteins (NS3 and NS3A) with Mr of 28K and 25K respectively were identified. The protein coding assignments for the medium- and small-sized double-stranded RNA genome segments of BTV serotype 10 were found to correspond to those reported for BTV-1 and BTV-17. The peptide maps of NS1, NS2, NS3 and NS3A synthesized in vitro corresponded to those of their counterparts synthesized in infected cells. Protein NS3A appeared to be a truncated form of NS3, since its peptide map completely overlapped that of NS3. Proteins NS3 and NS3A were present in very small amounts in the soluble fraction of the cytoplasm of infected cells, and were synthesized in variable amounts in vitro, whereas the other nine viral proteins were synthesized in constant molar ratios. A difference in the relative molar ratios in which some of the BTV proteins were synthesized in vitro and in vivo was observed. In vivo, protein NS1 was translated in the largest amount but in vitro, NS2 was the most efficiently translated protein. Conversely, protein P6 was translated much more efficiently in vitro than in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832524     DOI: 10.1099/0022-1317-69-3-573

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  25 in total

1.  Expression of two related nonstructural proteins of bluetongue virus (BTV) type 10 in insect cells by a recombinant baculovirus: production of polyclonal ascitic fluid and characterization of the gene product in BTV-infected BHK cells.

Authors:  T J French; S Inumaru; P Roy
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

2.  Expression of nonstructural protein NS3 of African horsesickness virus (AHSV): evidence for a cytotoxic effect of NS3 in insect cells, and characterization of the gene products in AHSV infected Vero cells.

Authors:  V van Staden; M A Stoltz; H Huismans
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.

Authors:  Mani Saminathan; Karam Pal Singh; Jaynudin Hajibhai Khorajiya; Murali Dinesh; Sobharani Vineetha; Madhulina Maity; At Faslu Rahman; Jyoti Misri; Yashpal Singh Malik; Vivek Kumar Gupta; Raj Kumar Singh; Kuldeep Dhama
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

4.  Adaptation of bluetongue virus in mosquito cells results in overexpression of NS3 proteins and release of virus particles.

Authors:  F Guirakhoo; J A Catalan; T P Monath
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 5.  The molecular biology of Bluetongue virus replication.

Authors:  Avnish Patel; Polly Roy
Journal:  Virus Res       Date:  2013-12-25       Impact factor: 3.303

6.  Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation.

Authors:  Eiko Matsuo; Polly Roy
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

7.  Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge.

Authors:  Eiko Matsuo; Cristina C P Celma; Mark Boyce; Cyril Viarouge; Corinne Sailleau; Eric Dubois; Emmanuel Bréard; Richard Thiéry; Stéphan Zientara; Polly Roy
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

8.  Bluetongue virus entry into cells.

Authors:  Mario Forzan; Mark Marsh; Polly Roy
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

Review 9.  Bluetongue: a historical and epidemiological perspective with the emphasis on South Africa.

Authors:  Peter Coetzee; Maria Stokstad; Estelle H Venter; Mette Myrmel; Moritz Van Vuuren
Journal:  Virol J       Date:  2012-09-13       Impact factor: 4.099

10.  Minimum requirements for bluetongue virus primary replication in vivo.

Authors:  Eiko Matsuo; Polly Roy
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.